nach oben

Current Behavioral Neuroscience Reports

Erschienen in:

01.03.2014 | Addictions (H Kranzler, Section Editor)

Neuroimaging in Alcohol and Drug Dependence

verfasst von: Mark J. Niciu, Graeme F. Mason

Erschienen in: Current Behavioral Neuroscience Reports | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Neuroimaging, including PET, MRI, and MRS, is a powerful approach to the study of brain function. This article reviews neuroimaging findings related to alcohol and other drugs of abuse that have been published since 2011. Uses of neuroimaging are to characterize patients to determine who will fare better in treatment and to investigate the reasons underlying the effect on outcomes. Neuroimaging is also used to characterize the acute and chronic effects of substances on the brain and how those effects are related to dependence, relapse, and other drug effects. The data can be used to provide encouraging information for patients, as several studies have shown that long-term abstinence is associated with at least partial normalization of neurological abnormalities.

Buhler M, Mann K. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res. 2011;35:1771–93.PubMed

Weerts EM, Wand GS, Kuwabara H, et al. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcohol Clin Exp Res. 2011;35:2162–73.PubMedCentralPubMed

Spreckelmeyer KN, Paulzen M, Raptis M, et al. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study. Biol Psychiatry. 2011;70:770–6.PubMed

Lingford-Hughes A, Reid AG, Myers J, et al. A [11C] Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced alpha5 benzodiazepine receptors in limbic regions. J Psychopharmacol. 2012;26:273–81.PubMed

Neumeister A, Normandin MD, Murrough JW, et al. Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence. Alcohol Clin Exp Res. 2012;36:2104–9.PubMedCentralPubMed

Hirvonen J, Zanotti-Fregonara P, Umhau JC, et al. Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry. 2013;18:916–21.PubMed

Momenan R, Steckler LE, Saad ZS, et al. Effects of alcohol dependence on cortical thickness as determined by magnetic resonance imaging. Psychiatry Res. 2012;204:101–11.PubMed

Kroenke CD, Rohlfing T, Park B, et al. Monkeys that voluntarily and chronically drink alcohol damage their brains: a longitudinal MRI study. Neuropsychopharmacology 2013.

Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol. 2011;7:284–94.PubMed

10.

Schulte T, Müller-Oehring E, Sullivan E, et al. White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia. 2012;50(12):2812–22.PubMedCentralPubMed

11.

Alhassoon OM, Sorg SF, Taylor MJ, et al. Callosal white matter microstructural recovery in abstinent alcoholics: a longitudinal diffusion tensor imaging study. Alcohol Clin Exp Res. 2012;36:1922–31.PubMed

12.

Vollstädt‐Klein S, Loeber S, Richter A, et al. Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol‐dependent patients. Addict Biol. 2012;17:807–16.PubMed

13.

Krienke UJ, Nikesch F, Spiegelhalder K, et al. Impact of alcohol-related video sequences on functional MRI in abstinent alcoholics. Eur Addict Res. 2013;20:33–40.PubMed

14.

Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013;18:121–33.PubMedCentralPubMed

15.

Bednarski SR, Erdman E, Luo X, et al. Neural processes of an indirect analog of risk taking in young nondependent adult alcohol drinkers-an FMRI study of the stop signal task. Alcohol Clin Exp Res. 2012;36:768–79.PubMedCentralPubMed

16.

Beltz AM, Gates KM, Engels AS, et al. Changes in alcohol-related brain networks across the first year of college: a prospective pilot study using fMRI effective connectivity mapping. Addict Behav. 2013;38:2052–9.PubMed

17.

Blaine S, Claus E, Harlaar N, et al. TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin Exp Res. 2013;37 Suppl 1:E125–30.PubMed

18.

Langosch JM, Spiegelhalder K, Jahnke K, et al. The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study. J Clin Psychopharmacol. 2012;32:661–5.PubMed

19.

Umhau JC, Momenan R, Schwandt ML, et al. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry. 2010;67:1069–77.PubMedCentralPubMed

20.

Lukas SE, Lowen SB, Lindsey KP, et al. Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study. Neuroimage. 2013;78:176–85.PubMed

21.

Thoma R, Mullins P, Ruhl D, et al. Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology. 2011;36:1359–65.PubMed

22.

Bauer J, Pedersen A, Scherbaum N, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacology. 2013;38:1401–8.PubMed

23.

Abé C, Mon A, Hoefer ME, et al. Metabolic abnormalities in lobar and subcortical brain regions of abstinent polysubstance users: Magnetic Resonance Spectroscopic Imaging. Alcohol Alcohol. 2013;48:543–51.PubMed

24.

Hermann D, Weber-Fahr W, Sartorius A, et al. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry. 2012;71:1015–21.PubMed

25.

Gomez R, Behar KL, Watzl J, et al. Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 Tesla. Biol Psychiatry. 2012;71:239–46.PubMedCentralPubMed

26.

Volkow ND, Wang GJ, Franceschi D, et al. Low doses of alcohol substantially decrease glucose metabolism in the human brain. Neuroimage. 2006;29:295–301.PubMed

27.••

Volkow ND, Kim SW, Wang GJ, et al. Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain. Neuroimage. 2013;64:277–83.PubMedCentralPubMed

28.••

Jiang L, Gulanski BI, De Feyter HM, et al. Increased brain uptake and oxidation of acetate in heavy drinkers. J Clin Invest. 2013;123:1605–14. These references together demonstrate that heavy drinkers possess a greater ability to oxidize acetate than light drinkers do. It may be that chronic heavy drinking leads the brain to become dependent on acetate, either for its energy or for metabolic byproducts of its oxidation, like adenosine.PubMedCentralPubMed

29.

Wang J, Du H, Ma X, et al. Metabolic products of [2-¹³C] ethanol in the rat brain after chronic ethanol exposure. J Neurochem. 2013;127:353–64.PubMed

30.

Pawlosky RJ, Kashiwaya Y, Srivastava S, et al. Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat. Alcohol Clin Exp Res. 2010;34:375–81.PubMedCentralPubMed

31.••

Wang J, Du H, Jiang L, et al. Oxidation of ethanol in the rat brain and effects associated with chronic ethanol exposure. Proc Natl Acad Sci. 2013;110:14444–9. The demonstration that living, intact brain oxidizes ethanol provides feasibility data for the concept of ethanol’s breakdown product, acetaldehyde, serving as an intracerebral reward.PubMed

32.

Deehan GA, Engleman EA, Ding ZM, et al. Microinjections of acetaldehyde or salsolinol into the posterior ventral tegmental area increase dopamine release in the nucleus accumbens shell. Alcohol Clin Exp Res. 2012;37:722–9.PubMed

33.

Karahanian E, Quintanilla ME, Tampier L, et al. Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res. 2011;35:606–12.PubMedCentralPubMed

34.

Derr RF, Draves K, Derr M. Abatement by acetate of an ethanol withdrawal syndrome. Life Sci. 1981;29:1787–90.PubMed

35.

Carmichael FJ, Israel Y, Crawford M, et al. Central nervous system effects of acetate: contribution to the central effects of ethanol. J Pharmacol Exp Ther. 1991;259:403–8.PubMed

36.

Le Foll B, Guranda M, Wilson AA, et al. Elevation of dopamine induced by cigarette smoking: novel insights from a [¹¹C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 2013.

37.

Brody AL, Mandelkern MA, Olmstead RE, et al. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology. 2009;34:282–9.PubMedCentralPubMed

38.

Chiuccariello L, Boileau I, Guranda M, et al. Presentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: a [¹¹C]-(+)-PHNO PET study. PLoS One. 2013;8:e60382.PubMedCentralPubMed

39.

Domino EF, Ni L, Domino JS, et al. Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine. Nicotine Tobacco Res. 2013;15:11–21.

40.

Brody AL, Mandelkern MA, Costello MR, et al. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol. 2009;12:305–16.PubMedCentralPubMed

41.

Brody AL, Mandelkern MA, London ED, et al. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry. 2011;68:953–60.PubMedCentralPubMed

42.

Kuwabara H, Wong DF, Gao Y, et al. PET imaging of nicotinic acetylcholine receptors in baboons with ¹⁸ F-AZAN, a radioligand with improved brain kinetics. J Nucl Med. 2012;53:121–9.PubMed

43.

Wong DF, Kuwabara H, Kim J, et al. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with ¹⁸ F-AZAN, a radioligand with optimal brain kinetics. J Nucl Med. 2013;54:1308–14.PubMed

44.

Akkus F, Ametamey SM, Treyer V, et al. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [¹¹C] ABP688 positron emission tomography. Proc Natl Acad Sci U S A. 2013;110:737–42.PubMedCentralPubMed

45.

Hulka L, Treyer V, Scheidegger M, et al. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans. Molecular psychiatry 2013.

46.

Claus ED, Blaine SK, Filbey FM, et al. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology. 2013;38(12):2363–72.PubMed

47.

Falcone M, Wileyto EP, Ruparel K, et al. Age-related differences in working memory deficits during nicotine withdrawal. Addiction Biology 2013.

48.

Froeliger B, Modlin L, Wang L, et al. Nicotine withdrawal modulates frontal brain function during an affective Stroop task. Psychopharmacology (Berl). 2012;220:707–18.

49.

Rose EJ, Ross TJ, Salmeron BJ, et al. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biol Psychiatry. 2013;73:280–8.PubMed

50.

Hartwell KJ, Lematty T, McRae-Clark AL, et al. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. Am J Drug Alcohol Abuse. 2013;39:92–8.PubMed

51.

Kochunov P, Du X, Moran LV, et al. Acute nicotine administration effects on fractional anisotropy of cerebral white matter and associated attention performance. Front Parmacology. 2013;4:117.

52.

Gazdzinski S, Durazzo TC, Mon A, et al. Cerebral white matter recovery in abstinent alcoholics—a multimodality magnetic resonance study. Brain. 2010;133:1043–53.PubMed

53.

Wang GJ, Smith L, Volkow ND, et al. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2011;17:918–25.PubMedCentralPubMed

54.

Groman SM, Lee B, Seu E, et al. Dysregulation of D2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci. 2012;32:5843–52.PubMedCentralPubMed

55.

Groman SM, Morales AM, Lee B, et al. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology 2013: 1-12.

56.

Boileau I, Payer D, Houle S, et al. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci. 2012;32:1353–9.PubMedCentralPubMed

57.

Cox SM, Benkelfat C, Dagher A, et al. Effects of lowered serotonin transmission on cocaine-induced striatal dopamine response: PET [¹¹C] raclopride study in humans. Br J Psychiatry. 2011;199:391–7.PubMed

58.

Michaelides M, Thanos PK, Kim R, et al. PET imaging predicts future body weight and cocaine preference. Neuroimage. 2012;59:1508–13.PubMedCentralPubMed

59.

Volkow ND, Tomasi D, Gene-Jack W, et al. Reduced metabolism in brain “control networks” following cocaine-cues exposure in female cocaine abusers. PLoS ONE. 2011;6:e16573.PubMedCentralPubMed

60.

Martínez D, Slifstein M, Nabulsi N, et al. Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [¹¹C]ABP688 and magnetic resonance spectroscopy. Biol Psychiatry 2013; in press.

61.

Mackey S, Paulus M. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehavl Rev. 2012;37:300–16.

62.

Mandeville JB, Choi J-K, Jarraya B, et al. FMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia. Neuropsychopharmacology. 2011;36:1187–98.PubMed

63.

Salo R, Fassbender C, Buonocore MH, et al. Behavioral regulation in methamphetamine abusers: an fMRI study. Psychiatry Res Neuroimaging 2012.

64.

Nestor LJ, Ghahremani DG, Monterosso J, et al. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res Neuroimaging. 2011;194:287–95.

65.

Prisciandaro JJ, McRae-Clark AL, Myrick H, et al. Brain activation to cocaine cues and motivation/treatment status. Addiction Biology 2012.

66.

Salo R, Buonocore MH, Leamon M, et al. Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study. Drug Alcohol Dep. 2011;113:133–8.

67.

Yang S, Belcher AM, Chefer S, et al. Withdrawal from long-term methamphetamine self-administration ‘normalizes’ neurometabolites in rhesus monkeys: a ¹H MR spectroscopy study. Addict Biol. 2013;17(1):100–2.

68.

Sung Y-H, Yurgelun-Todd DA, Shi X-F, et al. Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Dep. 2012;129:102–9.

69.

Sung Y-H, Carey PD, Stein DJ, et al. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res. 2013;6C:80–6.

70.

Albrecht DS, Skosnik PD, Vollmer JM, et al. Striatal D₂/D₃ receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Dep. 2012;128:52–7.

71.

Mizrahi R, Suridjan I, Kenk M, et al. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [¹¹C]-(+)-PHNO. Neuropsychopharmacology. 2012;38:673–82.PubMed

72.

Hirvonen J, Goodwin R, Li C, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2011;17:642–9.PubMedCentralPubMed

73.

Neumeister A, Normandin M, Pietrzak R, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Molecular Psychiatry 2013.

74.

Gruber SA, Dahlgren MK, Sagar KA, et al. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology 2013.

75.

Cousijn J, Wiers RW, Ridderinkhof KR, et al. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 2012;59:3845–51.PubMed

76.

King GR, Ernst T, Deng W, et al. Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci. 2011;31:17923–31.PubMedCentralPubMed

77.

Winton-Brown TT, Allen P, Bhattacharrya S, et al. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology. 2011;36:1340–8.PubMed

78.

Smith AM, Zunini RAL, Anderson CD, et al. Impact of marijuana on response inhibition: an fMRI study in young adults. J Behav Brain Sci. 2011;1:124–33.

79.

Wesley MJ, Hanlon CA, Porrino LJ. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res Neuroimaging. 2011;191:51–9.

80.

Sneider J, Mashhoon Y, Silveri M. A review of magnetic resonance spectroscopy studies in marijuana using adolescents and adults. J Addict Res Ther S. 2013;4:2.

81.

Silveri MM, Jensen JE, Rosso IM, et al. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res Neuroimaging. 2011;191:201–11.

82.

Mashhoon Y, Jensen J, Sneider J, et al. Lower left thalamic myo-inositol levels associated with greater cognitive impulsivity in marijuana-dependent young men: preliminary spectroscopic evidence at 4 T. J Addict Res Ther S. 2013;4:2.

83.

Martinez D, Saccone PA, Liu F, et al. Deficits in dopamine D₂ receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry. 2012;71:192–8.PubMedCentralPubMed

84.

Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, et al. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One. 2012;7:e39830.PubMedCentralPubMed

85.

Bora E, Yücel M, Fornito A, et al. White matter microstructure in opiate addiction. Addict Biol. 2013;17:141–8.

86.

Qiu Y, Jiang G, Su H, et al. Progressive white matter microstructure damage in male chronic heroin dependent individuals: a DTI and TBSS study. PLoS One. 2013;8:e63212.PubMedCentralPubMed

87.

Schmidt A, Walter M, Gerber H, et al. Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology. 2013;38(11):2231–9.PubMed

88.

Hermann D, Frischknecht U, Heinrich M, et al. MR spectroscopy in opiate maintenance therapy: association of glutamate with the number of previous withdrawals in the anterior cingulate cortex. Addict Biol. 2011;17:659–67.PubMed

89.

Verdejo-García A, Lubman DI, Roffel K, et al. Cingulate biochemistry in heroin users on substitution pharmacotherapy. Aust N Z J Psychiatry. 2013;47:244–9.PubMed

90.

Frischknecht U, Hermann D, Heinrich M, et al. Experience of social discrimination correlates with neurometabolism: a pilot study in heroin addicts. Eur Arch Psyc Clin Neurosci. 2012;263:197–203.

91.

Domino EF, Minoshima S, Guthrie S, et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse. 2000;38:313–21.PubMed

92.

Zubieta J-K, Lombardi U, Minoshima S, et al. Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry. 2001;49:906–13.PubMed

93.

Domino EF, Ni L, Xu Y, et al. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Prog Neuro-Psychopharm Biol Psychiatry. 2004;28:319–27.

94.

Kubota K, Yamaguchi T, Abe Y, et al. Effects of smoking on regional cerebral blood flow in neurologically normal subjects. Stroke. 1983;14:720–4.PubMed

95.

Skinhϕj E, Olesen J, Paulson O. Influence of smoking and nicotine on cerebral blood flow and metabolic rate of oxygen in man. J App Physiology. 1973;35:820–2.

96.

Gundersen H, van Wageningen H, Gruner R. Alcohol-induced changes in cerebral blood flow and cerebral blood volume in social drinkers. Alcohol Alcohol. 2013;48:160–5.PubMed

97.

Volkow ND, Mullani N, Gould L, et al. Effects of acute alcohol intoxication on cerebral blood flow measured with PET. Psychiatry Res. 1988;24:201–9.PubMed

98.

Sano M, Wendt PE, Wirsén A, et al. Acute effects of alcohol on regional cerebral blood flow in man. J Stud Alcohol Drugs. 1993;54:369.

99.

Schwartz JA, Speed NM, Gross MD, et al. Acute effects of alcohol administration on regional cerebral blood flow: the role of acetate. Alcohol Clin Exp Res. 1993;17:1119–23.PubMed

100.

Mathew R, Wilson W. Regional cerebral blood flow changes associated with ethanol intoxication. Stroke. 1986;17:1156–9.PubMed

101.

Lotfi J, Meyer J. Cerebral hemodynamic and metabolic effects of chronic alcoholism. Cerebrovasc Brain Metab Rev. 1989;1:2–25.PubMed

102.

Christie IC, Price J, Edwards L, et al. Alcohol consumption and cerebral blood flow among older adults. Alcohol. 2008;42:269–75.PubMedCentralPubMed

103.

Melgaard B, Henriksen L, Ahlgren P, et al. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography. Acta Neurol Scand. 1990;82:87–93.PubMed

104.

Berglund M, Risberg J. Regional cerebral blood flow during alcohol withdrawal. Arch Gen Psychiatry. 1981;38:351–5.PubMed

105.

Caspari D, Trabert W, Heinz G, et al. The pattern of regional cerebral blood flow during alcohol withdrawal‐a single photon emission tomography study with 99mTc‐HMPAO. Acta Psychiatr Scand. 1993;87:414–7.PubMed

106.

Tutus A, Kuğu N, Sofuoğlu S, et al. Transient frontal hypoperfusion in Tc-99 m hexamethylpropyleneamineoxime single photon emission computed tomography imaging during alcohol withdrawal. Biol Psychiatry. 1998;43:923–8.PubMed

107.

Ances BM, Vaida F, Cherner M, et al. HIV and chronic methamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011;6:409–19.PubMedCentralPubMed

108.

Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacol Ther. 2010;125:363–75.PubMed

109.

Chung YA, Peterson BS, Yoon SJ, et al. In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine. Drug Alcohol Dep. 2010;111:155–60.

110.

Polesskaya O, Silva J, Sanfilippo C, et al. Methamphetamine causes sustained depression in cerebral blood flow. Brain Res. 2011;1373:91–100.PubMedCentralPubMed

111.••

Yuan Z, Luo Z, Volkow ND, et al. Imaging separation of neuronal from vascular effects of cocaine on rat cortical brain in vivo. Neuroimage. 2011;54:1130–9. Neuronal and vascular effects can be difficult to deconvolve with neuroimaging and is likely to confound results in many cases. This study demonstrates the importance of that notion.PubMedCentralPubMed

Titel: Neuroimaging in Alcohol and Drug Dependence
verfasst von: Mark J. Niciu
Graeme F. Mason
Publikationsdatum: 01.03.2014
Verlag: Springer International Publishing
Erschienen in: Current Behavioral Neuroscience Reports / Ausgabe 1/2014
Elektronische ISSN: 2196-2979
DOI: https://doi.org/10.1007/s40473-013-0005-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Excessive Internet Use and Personality Traits

Gambling and Personality Dimensions

The Genetics, Neurogenetics and Pharmacogenetics of Addiction

Body Focused Repetitive Behaviors (BFRBs) and Personality Features